Key Sessions
Fouad Atouf
PLENARY KEYNOTE: Evolving Pharmacopeial Standards to Shape the Future of Biological Medicines
US Pharmacopeia
Amy Shaw
Scale-Out Versus Scale-Up Strategies for Maximizing Cellular Therapies
Takeda, USA
Kelvin Lee
KEYNOTE: The Future of Biopharmaceutical Manufacturing: Innovation and Collaboration
NIIMBL
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Wednesday 17th September - Main Conference Day Two - ET (Eastern Time, GMT-05:00)
keyboard_arrow_leftSearch & Filter
close
Streams
Wednesday 17th September - Main Conference Day Two - ET (Eastern Time, GMT-05:00)
close
Streams
Showing 1 of 1 Streams
Cell Therapy Manufacturing & Analytics
10:00am - 10:30am
Bringing Cell Therapy to the Patient—Implementing Decentralized Manufacturing
- Francesca Vitelli, PhD - VP Global head of Process and Analytical Development and Innovation (PADI), Minaris
- Spencer Hoover - Principal Consultant, SH Consulting LLC
- Therese Choquette - Head of Analytical and Translational Sciences, Tigen Pharma
- Thomas Perroud - Global Head of R&D – Personalized Medicine, Lonza
- Nina Bauer - Independent Consultant, Independent Consultant
Showing 1 of 1 Streams
Showing 1 of 1 Streams
Showing 1 of 1 Streams
Innovation and Community Stage (Exhibit Hall)
3:45pm - 4:00pm
One-Lonza: A Unified Approach to Bioproduction
Join us to explore how Lonza’s integrated solutions, from licensing and CHO media to biologics services, streamline the path from discovery to commercialization. Learn how we support customers with end-to-end expertise, global scale, and trusted execution.
- Sanjay Kumar - Head of Technical Excellence, Lonza
- Caroline Mahl - Team Lead, Cell Culture Development, Lonza
- Shawn Sommer - Associate Director, Business Development, Lonza
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
